<p> 좌약용 지방성 기제 세계 시장은 2021년 1억 9,790만 달러에서 2031년까지 3억 3,950만 달러에 달할 전망이며, 2022년부터 2031년까지 CAGR은 5.59%로 예상되고 있습니다.</p>

The global fatty bases for suppositories market is envisioned to garner $339.5 million by 2031, growing from $197.9 million in 2021, at a CAGR of 5.59% from 2022 to 2031.

A suppository is a solid form of medication that is intended to be inserted into bodily cavities other than the mouth. They can be inserted in the vaginal canal, rectum, or urethra. After being inserted, the objects melt or dissolve in the fluids of the cavity, releasing the medicines. Rectal, vaginal, and urethral suppositories are available, each with a different insertion location. These medicines also have an effect locally. Additionally, there is no first-pass action, which stops the drug's metabolism. Drugs that are bitter or offensive can be delivered effectively using suppositories. Suppositories are frequently used in paediatric medicine to address constipation-related symptoms.

Primarily in pediatric and geriatric patients, the fat-based excipients play a significant role in drug delivery. For drug delivery among pediatric and geriatric populations, the rectal route is a great alternative. Over the anticipated period, the market growth is anticipated to be aided by the rising demand for fat-based suppositories due to their benefits, including the quick absorption of several low molecular weight drugs and the potential for lymphatic system absorption. Although fatty bases for suppositories have a long history of use in rectal and vaginal drug delivery, the current global market for these products is constrained primarily by a lack of consumer acceptance and willingness to use rectal products. Additionally, it is thought that the difficulties in producing oil-based suppositories will somewhat restrain the market expansion.

The fatty basses for suppositories market is being driven by rising healthcare expenditure in developed countries and an ageing population. In these populations, the rectal route is an ideal choice for medication delivery. Growing demand for suppositories is likely to support market expansion over the forecast period due to benefits such as quick absorption of certain low molecular weight pharmaceuticals and the possibility of absorption into the lymphatic system. The suppositories sector is expected to rise as a result of improved physical and chemical stability, neutrality toward mucosal membranes, and full compatibility with almost all active compounds. This helps to the global fatty bases for suppositories market growth. These factors are further expected to propel the global fatty bases suppositories market growth.

During the COVID-19 pandemic surge, self-medication was a common practice for taking medications. Numerous treatment facilities and clinics with just single doctor had to close due to the pandemic, depriving the general public of timely medical care. The pandemic has encouraged self-medication. Topical corticosteroids were the self-medication methods that were most widely used. The most widely used topical drugs included anti-acne drugs, corticosteroids, combos (corticosteroids, antibiotics, and antifungals), moisturizers, and suppositories. The rise in demand for over-the-counter and topical medications brought on by self-medication has benefited the market for suppositories.

The key players profiled in this report include Unither, Bliss GVS Pharma Ltd., Delpharm, ATRAL, Aenova Holding GmBH, FAMAR, LGV (Laboratories Mayoly Spindler), and Priyans Drugs.

Key Benefits For Stakeholders

• This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the fatty bases for suppositories market analysis from 2021 to 2031 to identify the prevailing fatty bases for suppositories market opportunities.
• The market research is offered along with information related to key drivers, restraints, and opportunities.
• Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
• In-depth analysis of the fatty bases for suppositories market segmentation assists to determine the prevailing market opportunities.
• Major countries in each region are mapped according to their revenue contribution to the global market.
• Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
• The report includes the analysis of the regional as well as global fatty bases for suppositories market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Base Type

• Hard Fat
• Water Miscible Base
• Emulsifying Bases

By Region

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • United Kingdom
  • France
  • Spain
  • Italy
  • Rest of Europe
• Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest Of Asia Pacific
• LAMEA
  • Brazil
  • Saudi Arabia
  • UAE
  • South Africa
  • Rest of LAMEA
• Key Market Players
  • IOI Oleo GmbH
  • SpecializedRx Products, LLC
  • CD Formulation
  • Dow
  • Croda International Plc
  • STEARINERIE DUBOIS
  • Gattefosse
  • Tianshui Huayuan Pharmaceutical Equipment technology Co.,ltd

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

• 1.1.Report description
• 1.2.Key market segments
• 1.3.Key benefits to the stakeholders
• 1.4.Research Methodology
  • 1.4.1.Secondary research
  • 1.4.2.Primary research
  • 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

• 2.1.Key findings of the study
• 2.2.CXO Perspective

CHAPTER 3:MARKET OVERVIEW

• 3.1.Market definition and scope
• 3.2.Key findings
  • 3.2.1.Top investment pockets
• 3.3.Porter's five forces analysis
• 3.4.Top player positioning
• 3.5.Market dynamics
  • 3.5.1.Drivers
  • 3.5.2.Restraints
  • 3.5.3.Opportunities
• 3.6.COVID-19 Impact Analysis on the market
• 3.7.Regulatory Guidelines
• 3.8.Value Chain Analysis
• 3.9.Market Share Analysis
• 3.10.Key Regulation Analysis
• 3.11.Patent Landscape

CHAPTER 4: FATTY BASES FOR SUPPOSITORIES MARKET, BY BASE TYPE

• 4.1 Overview
  • 4.1.1 Market size and forecast
• 4.2 Hard Fat
  • 4.2.1 Key market trends, growth factors and opportunities
  • 4.2.2 Market size and forecast, by region
  • 4.2.3 Market analysis by country
• 4.3 Water Miscible Base
  • 4.3.1 Key market trends, growth factors and opportunities
  • 4.3.2 Market size and forecast, by region
  • 4.3.3 Market analysis by country
• 4.4 Emulsifying Bases
  • 4.4.1 Key market trends, growth factors and opportunities
  • 4.4.2 Market size and forecast, by region
  • 4.4.3 Market analysis by country

CHAPTER 5: FATTY BASES FOR SUPPOSITORIES MARKET, BY REGION

• 5.1 Overview
  • 5.1.1 Market size and forecast
• 5.2 North America
  • 5.2.1 Key trends and opportunities
  • 5.2.2 North America Market size and forecast, by Base Type
  • 5.2.3 North America Market size and forecast, by country
    • 5.2.3.1 U.S.
    • 5.2.3.1.1 Market size and forecast, by Base Type
    • 5.2.3.2 Canada
    • 5.2.3.2.1 Market size and forecast, by Base Type
    • 5.2.3.3 Mexico
    • 5.2.3.3.1 Market size and forecast, by Base Type
• 5.3 Europe
  • 5.3.1 Key trends and opportunities
  • 5.3.2 Europe Market size and forecast, by Base Type
  • 5.3.3 Europe Market size and forecast, by country
    • 5.3.3.1 Germany
    • 5.3.3.1.1 Market size and forecast, by Base Type
    • 5.3.3.2 United Kingdom
    • 5.3.3.2.1 Market size and forecast, by Base Type
    • 5.3.3.3 France
    • 5.3.3.3.1 Market size and forecast, by Base Type
    • 5.3.3.4 Spain
    • 5.3.3.4.1 Market size and forecast, by Base Type
    • 5.3.3.5 Italy
    • 5.3.3.5.1 Market size and forecast, by Base Type
    • 5.3.3.6 Rest of Europe
    • 5.3.3.6.1 Market size and forecast, by Base Type
• 5.4 Asia-Pacific
  • 5.4.1 Key trends and opportunities
  • 5.4.2 Asia-Pacific Market size and forecast, by Base Type
  • 5.4.3 Asia-Pacific Market size and forecast, by country
    • 5.4.3.1 China
    • 5.4.3.1.1 Market size and forecast, by Base Type
    • 5.4.3.2 Japan
    • 5.4.3.2.1 Market size and forecast, by Base Type
    • 5.4.3.3 India
    • 5.4.3.3.1 Market size and forecast, by Base Type
    • 5.4.3.4 South Korea
    • 5.4.3.4.1 Market size and forecast, by Base Type
    • 5.4.3.5 Australia
    • 5.4.3.5.1 Market size and forecast, by Base Type
    • 5.4.3.6 Rest Of Asia Pacific
    • 5.4.3.6.1 Market size and forecast, by Base Type
• 5.5 LAMEA
  • 5.5.1 Key trends and opportunities
  • 5.5.2 LAMEA Market size and forecast, by Base Type
  • 5.5.3 LAMEA Market size and forecast, by country
    • 5.5.3.1 Brazil
    • 5.5.3.1.1 Market size and forecast, by Base Type
    • 5.5.3.2 Saudi Arabia
    • 5.5.3.2.1 Market size and forecast, by Base Type
    • 5.5.3.3 UAE
    • 5.5.3.3.1 Market size and forecast, by Base Type
    • 5.5.3.4 South Africa
    • 5.5.3.4.1 Market size and forecast, by Base Type
    • 5.5.3.5 Rest of LAMEA
    • 5.5.3.5.1 Market size and forecast, by Base Type

CHAPTER 6: COMPANY LANDSCAPE

• 6.1. Introduction
• 6.2. Top winning strategies
• 6.3. Product Mapping of Top 10 Player
• 6.4. Competitive Dashboard
• 6.5. Competitive Heatmap
• 6.6. Key developments

CHAPTER 7: COMPANY PROFILES

• 7.1 IOI Oleo GmbH
  • 7.1.1 Company overview
  • 7.1.2 Company snapshot
  • 7.1.3 Operating business segments
  • 7.1.4 Product portfolio
  • 7.1.5 Business performance
  • 7.1.6 Key strategic moves and developments
• 7.2 SpecializedRx Products, LLC
  • 7.2.1 Company overview
  • 7.2.2 Company snapshot
  • 7.2.3 Operating business segments
  • 7.2.4 Product portfolio
  • 7.2.5 Business performance
  • 7.2.6 Key strategic moves and developments
• 7.3 CD Formulation
  • 7.3.1 Company overview
  • 7.3.2 Company snapshot
  • 7.3.3 Operating business segments
  • 7.3.4 Product portfolio
  • 7.3.5 Business performance
  • 7.3.6 Key strategic moves and developments
• 7.4 Dow
  • 7.4.1 Company overview
  • 7.4.2 Company snapshot
  • 7.4.3 Operating business segments
  • 7.4.4 Product portfolio
  • 7.4.5 Business performance
  • 7.4.6 Key strategic moves and developments
• 7.5 Croda International Plc
  • 7.5.1 Company overview
  • 7.5.2 Company snapshot
  • 7.5.3 Operating business segments
  • 7.5.4 Product portfolio
  • 7.5.5 Business performance
  • 7.5.6 Key strategic moves and developments
• 7.6 STEARINERIE DUBOIS
  • 7.6.1 Company overview
  • 7.6.2 Company snapshot
  • 7.6.3 Operating business segments
  • 7.6.4 Product portfolio
  • 7.6.5 Business performance
  • 7.6.6 Key strategic moves and developments
• 7.7 Gattefosse
  • 7.7.1 Company overview
  • 7.7.2 Company snapshot
  • 7.7.3 Operating business segments
  • 7.7.4 Product portfolio
  • 7.7.5 Business performance
  • 7.7.6 Key strategic moves and developments
• 7.8 Tianshui Huayuan Pharmaceutical Equipment technology Co.,ltd
  • 7.8.1 Company overview
  • 7.8.2 Company snapshot
  • 7.8.3 Operating business segments
  • 7.8.4 Product portfolio
  • 7.8.5 Business performance
  • 7.8.6 Key strategic moves and developments